EGFR and rectal cancer: For this analysis, VEGFR3, EGFR, and COX2 were assayed in an independent set of plasma consisting of samples collected from 18 rectal cancer patients at the time of diagnosis and 5 to 7 months after surgical resection (pre-and post-surgery RC set; Figure 4A).